Han Zunsheng, Xia Zhonghua, Xia Jie, Tetko Igor V, Wu Song
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Munich - German Research Center for Environmental Health (GmbH), Ingolstädter Landstraße 1, 85764 Neuherberg, Germany.
Eur J Pharm Sci. 2025 Jan 1;204:106946. doi: 10.1016/j.ejps.2024.106946. Epub 2024 Oct 28.
Plasma protein binding (PPB) is closely related to pharmacokinetics, pharmacodynamics and drug toxicity. Existing models for predicting PPB often suffer from low prediction accuracy and poor interpretability, especially for high PPB compounds, and are most often not experimentally validated. Here, we carried out a strict data curation protocol, and applied consensus modeling to obtain a model with a coefficient of determination of 0.90 and 0.91 on the training set and the test set, respectively. This model (available on the OCHEM platform https://ochem.eu/article/29) was further retrospectively validated for a set of 63 poly-fluorinated molecules and prospectively validated for a set of 25 highly diverse compounds, and its performance for both these sets was superior to that of the other previously reported models. Furthermore, we identified the physicochemical and structural characteristics of high and low PPB molecules for further structural optimization. Finally, we provide practical and detailed recommendations for structural optimization to decrease PPB binding of lead compounds.
血浆蛋白结合(PPB)与药代动力学、药效学和药物毒性密切相关。现有的预测PPB的模型往往预测准确性低且解释性差,尤其是对于高PPB化合物,并且大多未经实验验证。在此,我们执行了严格的数据整理方案,并应用共识建模分别在训练集和测试集上获得了决定系数为0.90和0.91的模型。该模型(可在OCHEM平台https://ochem.eu/article/29上获取)对一组63个多氟分子进行了回顾性验证,并对一组25个高度多样化的化合物进行了前瞻性验证,其在这两组化合物上的性能均优于其他先前报道的模型。此外,我们确定了高PPB和低PPB分子的物理化学和结构特征,以进行进一步的结构优化。最后,我们为降低先导化合物的PPB结合提供了实用且详细的结构优化建议。